(Q48231741)

English

Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

1 reference

based on heuristic

inferred from title

fluticasone propionate

1 reference

based on heuristic

inferred from title

author name string

C A Sorkness

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

C LaForce

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

W Storms

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

W R Lincourt

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

L Edwards

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

P R Rogenes

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

21

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

353-367

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of inhaled corticosteroids and HPA axis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

How should inhaled glucocorticoids be compared?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988292-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(00)88292-2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10211538

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48231741&oldid=1508836771"